| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C13H19NO2 |
| Molar mass | 221.300 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
F-2, also known as6-(2-aminopropyl)-5-methoxy-2-methyl-2,3-dihydrobenzofuran or asbenzofuran-2-methyl-5-methoxy-6-(2-aminopropane), is a lesser-knownpsychedelic drug. F-2 was first synthesized byAlexander Shulgin. In his bookPiHKAL, the minimum dosage is listed as 15 mg, and its duration is unknown.[1] F-2 produces few to no effects at this dose in humans. Animal studies showed it to substitute for the psychedelic drugDOM, but with less than one tenth the potency.[2] F-2 is thederivative of6-APDB with amethyl group at thecarbonatom of the 3,4-methylenedioxy ring and amethoxy group at the 6 position.
This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[3]